Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apoptosis and therapy.

C A Schmitt1, S W Lowe

  • 1Cold Spring Harbor Laboratory, NY 11724, USA.

The Journal of Pathology
|May 26, 1999
PubMed
Summary
This summary is machine-generated.

Antineoplastic treatments can trigger programmed cell death (apoptosis), influenced by gene networks. Understanding apoptosis is key to improving cancer therapy outcomes and overcoming drug resistance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding homologous recombination repair deficiency in biliary tract cancers: clinical implications and correlation with platinum sensitivity.

ESMO open·2024
Same author

Comment on: Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma.

ESMO open·2024
Same author

Obesity and obesogenic growth are both highly heritable and modified by diet in a nonhuman primate model, the African green monkey (Chlorocebus aethiops sabaeus).

International journal of obesity (2005)·2017
Same author

EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia.

Leukemia·2016
Same author

Adult age confounds estimates of static allometric slopes in a vertebrate.

Ethology, ecology & evolution·2016
Same author

A common functional consequence of tumor-derived mutations within c-MYC.

Oncogene·2014
Same journal

Tumor Invasive Border Index (TIBI) in colorectal cancer: linking infiltrative morphology to molecular insights.

The Journal of pathology·2026
Same journal

Lipodystrophy and adipose tissue recovery are mediated by the Wnt/lipogenesis axis during skin fibrosis.

The Journal of pathology·2026
Same journal

Optical mapping reveals a higher level of large-scale structural variants in a family with paternally transmitted myotonic dystrophy and independent Parkinson's disease.

The Journal of pathology·2026
Same journal

FTO-mediated m6A modification of protein disulfide-isomerase activates VEGFA-VEGFR2 to suppress programmed cell death in osteosarcoma.

The Journal of pathology·2026
Same journal

Dopamine inhibits retinal pathological neovascularization in the oxygen-induced retinopathy mouse model.

The Journal of pathology·2026
Same journal

Aberrant alternative splicing of purinergic receptor P2RX4 prevents sensitivity towards combinatorial treatment in colorectal and pancreatic cancer.

The Journal of pathology·2026
See all related articles

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • The traditional view of cancer treatments causing cell death through damage is challenged.
  • Emerging evidence suggests treatments can initiate programmed cell death, known as apoptosis.
  • Gene networks regulating cell proliferation and survival play a crucial role in this response.

Purpose of the Study:

  • To explore the role of apoptosis in cancer treatment response.
  • To understand how genetic mutations affect apoptosis and drug resistance.
  • To provide a framework for developing novel cancer therapies.

Main Methods:

  • Review of existing literature on apoptosis and cancer therapy.
  • Analysis of gene expression patterns in normal and malignant cells.

Related Experiment Videos

  • Examination of clinical data linking anti-apoptotic mutations to treatment outcomes.

    • Main Results:

    • Mutations affecting apoptosis can lead to tumor cell drug resistance.
    • Genes modulating apoptosis in response to cytotoxic drugs are also involved in tumor development.
    • Clinical studies show a correlation between anti-apoptotic mutations and treatment failure.

    Conclusions:

    • Apoptosis is a critical cellular process influencing cancer therapy efficacy.
    • Targeting apoptosis pathways presents a promising strategy for novel cancer treatments.
    • Further research is needed to fully elucidate the role of apoptosis in radiation and drug-induced cell death.